Cloudbreak Therapeutics is a clinical-stage biotechnology company focusing on ocular drug development. Cloudbreak Therapeutics operates a capital efficient business model based upon VIC + 505b(2). We repurpose approved systemic drugs for ocular delivery to treat eye diseases and quickly advance drug candidates to complete proof-of-concept (POC) Phase II clinical trials and to out-license global rights for Phase III clinical trials, product registration, and commercialization. Fully embracing the pharmaceutical development ecosystem, we utilize contract research organizations (CRO) for non-clinical, CMC and clinical development to efficiently maximize capital for drug development.

Manufactures contact lens

Tung & Co. is a Hong Kong Chinese private company located in Hong Kong that provides legal services.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a united mission. Formerly Google Life Sciences, Verily's mission is to bring together technology and life sciences to uncover new truths about health and disease. Verily's multidisciplinary teams have access to advanced research tools, large-scale computing power, and unique technical expertise. They work with partners from across the industry and many fields of research to develop new technology, launch studies and start companies. The company was founded in 2015 and is based in San Francisco, California, United States.

Cloud Dispelling Biomedical Technology (Guangzhou) Co., Ltd., established on 2018-09-30, Business scope includes drug research and development(human stem cells,Except for genetic diagnosis and treatment technology);Pharmaceutical Research Services;Technology Import and Export;Medical Research and Experimental Development(human stem cells,Except for genetic diagnosis and treatment technology)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Wuhan Chuangboda Information Technology Co., Ltd., established on 2014-05-04, Business scope includes electronic products,Photovoltaic products,R&D and sales of computer software and hardware.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Avedro recently completed its US‐based, multi-centered, Phase III studies of corneal cross-linking for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Outside the United States, Avedro has commercialized both VibeX and its KXL System for performing Lasik Xtra and accelerated cross-linking. Additionally, Avedro is developing the science of Thermo‐biomechanics for therapeutic medical applications. The Keraflex® refractive correction procedure is the first technology developed from the Thermo‐biomechanics platform and is a non‐invasive, incision‐less ophthalmic procedure for flattening the cornea without the removal of tissue. Keraflex offers the unique ability to induce refractive change without weakening the cornea’s biomechanical integrity, as happens with Lasik and other refractive correction procedures. Keraflex is commercially available outside of the United States.

HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceuticals. It offers products such as medicine for digestion, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives, and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea.

The Lions Eye Institute (LEI) is an Australian medical research institute affiliated with the University of Western Australia. It was established in 1983 with support of the Lions Club of Australia and headquartered in the Perth suburb of Nedlands, Western Australia. The LEI is a not-for-profit centre of excellence that combines an ophthalmic clinic with scientific discovery developing techniques for the prevention of blindness and the reduction of pain from blinding eye conditions.

KeraVision engages in the development of a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia, and astigmatism, to offer an alternative to eyeglasses, contact lenses, and other vision correction surgical procedures. Its first product, intacs corneal ring segments, has been approved by the FDA for correcting mild myopia in the range of -1.0 to -3.0 diopters in patients who are 21 years of age or older, who have a stable refraction, and who have up to +1.0 diopter of astigmatism. It is currently conducting a Phase III clinical trial to expand its approved range of indication for myopia to include -0.75 to -1.0 diopter and -3.1 to -4.5 diopters.

SCHWIND eye-tech-solutions is the specialist for refractive and therapeutic corneal surgery. The company develops, produces and markets a comprehensive product portfolio for the treatment of ametropia and corneal diseases. In more than fifty-eight years of steady growth and development, the owner operated family enterprise has advanced from diagnostics technology supplier for ophthalmologic practices to technological leader in eye laser systems. SCHWIND is present in 125 countries worldwide. Sales and distribution takes place in Germany through the company´s own organisation, and in all other markets through carefully selected distribution partners. More than 100 highly qualified employees dedicate all their know-how and all their creativity to the aim of optimizing vision. About 1,400 SCHWIND laser systems have been already installed. Customers include refractive surgeons in eye practices, eye clinics, laser centers and university clinics.

National Bank of Arizona provides banking and financial services. It offers personal, commercial, real estate and business loans, checking and savings accounts, and debit and credit cards. The company was founded in 1984 and is headquartered in Phoenix, AZ.

Twenty/Twenty Therapeutics focuses on harnessing the convergence of AI and microelectronics to treat eye diseases.

Suzhou Jingzhi Medical Technology Co., Ltd., established on 2017-08-09, Business scope includes research and development,Production,Sales:Physical and electronic rehabilitation medical devices and equipment,medical technology products,Medical Precision Measuring Instruments,And provide related technology development,technology transfer,Technical Services.Research and development of mechatronic equipment,Production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:The second type of value-added telecommunications services;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Medical Research and Experimental Development;Manufacturing of experimental analysis instruments;Instrument Manufacturing;software sales;software development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Les Frères Lissac operates optical shop. The company was founded in 1919 and is headquartered in Clamart, France.

Fuzhou Okay Medical Technology Co., Ltd., established on 2020-08-25, Business scope includes general items:Medical Research and Experimental Development;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)